Synthetic Genomics' Exxon Biofuel Pact Worth Up to $300M | GenomeWeb

NEW YORK (GenomeWeb News) –Synthetic Genomics has struck a biofuel research and development agreement with ExxonMobil Research and Engineering Company that could bring in up to $300 million for the genomics firm, the companies said today.

The agreement to develop biofuel from photosynthetic algae that would be compatible with gasoline and diesel fuels could bring in $300 million to SGI if certain milestones are met. Exxon plans to spend up to another $300 million internally to support the program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."